Document is current
Any future updates will be listed below
-
Authors
Trottet, Cécile
Schürch, Manuel
Allam, Ahmed
Petelytska, Liubov
Castellví, Ivan
Bečvář, Radim
de Vries-Bouwstra, Jeska
Iannone, Florenzo
Carreira, Patricia
Truchetet, Marie-Elise
Cuomo, Giovanna
Rezus, Elena
Cantatore, Francesco Paolo
Simeón-Aznar, Carmen Pilar
Parvu, Magda
Dzhus, Marta
Distler, Oliver
Hoffmann-Vold, Anna-Maria
Krauthammer, Michael
,
Castellví, Ivan
de Vries-Bouwstra, Jeska
Bellando-Randone, Silvia
Walker, Ulrich Andreas
Cutolo, Maurizio
Rednic, Simona
Allanore, Yannick
Montecucco, Carlomaurizio
Novak, Srdjan
Kumánovics, Gábor
Kotyla, Przemyslaw
Zanatta, Elisabetta
Pirkmajer, Katja Perdan
Moroncini, Gianluca
Airó, Paolo
Radic, Mislav
Balbir-Gurman, Alexandra
Hunzelmann, Nico
Idolazzi, Luca
Mitrovic, Josko
Denton, Christopher
Vonk, Madelon
Colic, Jelena
Henes, Joerg
Foeldvari, Ivan
Bajocchi, Gianluigi
Santiago, Tânia
Stamenkovic, Bojana
De Santis, Maria
Ickinger, Claudia
Ananieva, Lidia P.
Sondergaard, Klaus
Szucs, Gabriella
Launay, David
Riccieri, Valeria
Balanescu, Andra
Gheorghiu, Ana Maria
Bergmann, Christina
Mouthon, Luc
Smith, Vanessa
Mogensen, Mette
Vanthuyne, Marie
Alegre Sancho, Juan Jose
Granel, Brigitte
de Souza Müller, Carolina
Agachi, Svetlana
Cauli, Alberto
Solanki, Kamal
Soliman, Eiman
Rosato, Edoardo
Foti, Rosario
Maurer, Britta
Olesinska, Marzena
Awad, Nihal
Blaise, Sophie
Senet, Patricia
Chatelus, Emmanuel
Litinsky, Ira
Del Galdo, Francesco
Kerzberg, Eduardo
Milas-Ahic, Jasminka
Limonta, Massimiliano
Marcoccia, Antonella
Martin, Thierry
Wojteczek, Anna
Riemekasten, Gabriela
Conceição Santos, Lélita da
Levy, Yair
de Araujo, Daniel Brito
Brzosko, Marek
Epis, Oscar Massimiliano
Sfikakis, Petros
Ramazan, Ana-Maria
Lescoat, Alain
Cerinic, Marco Matucci
Spierings, Julia
Atzeni, Fabiola
Kuwana, Masataka
Mekinian, Arsene
Martin, Mickaël
Boleto, Gonçalo
Del Papa, Nicoletta
Selvi, Enrico
Mosca, Marta
Gerth, Ulrich
Karadag, Duygu Temiz
Batalov, Anastas
Ginosyan, Knarik
Manukyan, Nune
Naffaa, Mohammad
Maglio, Cristina
Retuerto, Miriam
Iwata, Futoshi
Hinchcliff, Monique
Giacomelli, Roberto
Benvenuti, Francesco
Santos Carneiro, Helena
Rabaneda, Esther Vicente
Györfi, Andrea-Hermina
Lopez Nunez, Lilian Maria
De Angelis, Rossella
Carrión-Barberà, Irene
Brigante, Alejandro
Miedany, Yasser El
Mu, Rong
Daniel, Alexandra
de Paulis, Amato
Derk, Chris
Zhang, Lijun
Batko, Bogdan
Sole, Ivette Casafont
Lewandowska-Polak, Anna
Yan, Qingran
Duruöz, Tuncay
Colak, Seda
Guzmán, Janeth Villegas
Mora-Trujillo, Claudia
Chimenti, Maria Sole
El-Bakry, Samah A.
Alibaz-Oner, Fatma
-
Funding
Funding for this research was provided by:
Swiss National Science Foundation (201184, 201184, 201184, 201184)
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 17 August 2025
First Online: 1 September 2025
Competing interests
: A.H. has/had consultancy relationship with and/or has received research funding from or has served as a speaker for the following companies in the area of potential treatments for systemic sclerosis and its complications in the last 36 months: Abbvie, Avalyn, CallunaPharma, BMS, Boehringer Ingelheim, Genentech, Janssen, Merck Sharp&Dohme, Medscape, Novartis, Pliant therapeutics, Roche and Werfen. A.H. is a CTD-ILD ERS/EULAR convenor and a EULAR study group leader on the lung in rheumatic and musculoskeletal diseases.OD has/had consultancy relationship with and/or has received research funding from or has served as a speaker for the following companies in the area of potential treatments for systemic sclerosis and its complications in the last two years: 4P-Pharma, Abbvie, Acepodia, Aera, AnaMar, Anaveon AG, Argenx, Boehringer Ingelheim, BMS, Calluna, Cantargia AB, Citus AG, CSL Behring, Galderma, Galapagos, Hemetron AG, Innovaderm, Lilly, MSD Merck, Mitsubishi Tanabe; Nkarta Inc., Orion, Pilan, Quell, Scleroderma Research Foundation, EMD Serono, Topadur and UCB. Patent issued “mir-29 for the treatment of systemic sclerosis” (US8247389, EP2331143). OD is a co-founder of CITUS AG. All other authors declare no competing interests.
